DB:1COVChemicals
Covestro (DB:1COV) Stock Can Revenue Hold Up As Losses Deepen?
The market has spent the past few months treating Covestro as a recovery story, with the stock edging higher into the latest numbers. The earnings release instead lays bare a company still wrestling with heavy losses. Full year 2025 brought a reported loss of €644m on a trailing basis and a deeply negative basic earnings per share line, even as revenue sat above €12b.
For a chemicals producer that lives and dies on throughput and margins, the headline is simple: sales are ticking along while...